Jimmy Spelts
Psychiatric/Mental Health · Chesapeake, VANPI 1104423946
Payments from drug & device makers
Across 106 payments — averaging $27.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$401
- Otsuka America Pharmaceutical, Inc.$394
- Johnson & Johnson$332
- Supernus Pharmaceuticals, Inc.$294
- Neurocrine Biosciences, Inc.$290
- AbbVie$223
- plus $940 from 14 others
What the payments were for
- Food & beverage$2,77897%
- Education$973%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$119
- REXULTI$117
- QELBREE$114
- QUVIVIQ$106
- AUSTEDO$106
How this compares
$2,875 in reported general payments places this provider in the 85th percentile of 1,003 psychiatric/mental health providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $103,605 |
| Alprazolam ErAlprazolam | 20 | $586 |
| Buspirone Hcl | 17 | $385 |
| Hydroxyzine Hcl | 19 | $327 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $257 |
| Trazodone Hcl | 33 | $181 |
| Lorazepam | 14 | $139 |
| Lamotrigine | 11 | $118 |
| Quetiapine Fumarate | 18 | $59 |
| Lithium Carbonate ErLithium Carbonate | 11 | $56 |
| Sertraline Hcl | 15 | $27 |
| Alprazolam | 14 | $18 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $290 | $103,60512 claims |
| Almatica Pharma LLCSertraline Hcl | $17 | $2715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,003 psychiatric/mental health providers in Virginia.
Other psychiatric/mental health in Chesapeake
- Justin RayChesapeake$127K
- Katia HallChesapeake$88K
- Amanda SnowChesapeake$13K
- Jennifer MelilloChesapeake$11K
- Keesha StewartChesapeake$7K
- Sophia ZwirnerChesapeake$7K
- Christine GilmoreBedford$75K
- Sarah FaberNewport News$59K
- Kristine GarciaGlen Allen$46K
- Tonjanika BoydRichmond$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.